Abstract
Delivery of macromolecular nucleotides into the living cells holds a great promise for the development of new therapeutics. However, its abilities for adoptive immunotherapy, cell reprogramming, and primary cell transfection have been long-term hindered by the lack of a system that can locally deliver engineered therapeutic nucleotides (e.g., plasmids, siRNAs, miRNAs) without causing any side effects. In this chapter, the performance of a novel 3D nanoelectroporation system (3D NEP) is highlighted in three scenarios—adoptive immunotherapy, cell reprogramming, and adult mouse primary cardiomyocyte transfection. Detailed protocols were given to introduce the 3D NEP system assembly, as well as their applications in (1) natural killer (NK) cells transfection by delivery of chimeric antigen receptor (CAR) plasmids; (2) mouse embryonic fibroblasts transfection with OSKM factors; and (3) miR-29b molecular beacon (BMs) delivery into primary cardiomyocytes for interrogating the side effect of miR-29b-assisted treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agrahari V, Agrahari V, Mitra AK (2016) Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunities. Ther Deliv 7(4):257–278. https://doi.org/10.4155/tde-2015-0012
Lee YJ, Erazo-Oliveras A, Pellois JP (2010) Delivery of macromolecules into live cells by simple co-incubation with a peptide. Chembiochem 11(3):325–330. https://doi.org/10.1002/cbic.200900527
Qian L, Li D, Ma L, He T, Qi F, Shen J, Lu XA (2016) The novel anti-CD19 chimeric antigen receptors with humanized scFv (single-chain variable fragment) trigger leukemia cell killing. Cell Immunol 304-305:49–54. https://doi.org/10.1016/j.cellimm.2016.03.003
Chu J, Deng Y, Benson DM, He S, Hughes T, Zhang J, Peng Y, Mao H, Yi L, Ghoshal K, He X, Devine SM, Zhang X, Caligiuri MA, Hofmeister CC, Yu J (2014) CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma. Leukemia 28(4):917–927. https://doi.org/10.1038/leu.2013.279
Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR, Teachey DT, Chew A, Hauck B, Wright JF, Milone MC, Levine BL, June CH (2013) Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N Engl J Med 368(16):1509–1518. https://doi.org/10.1056/NEJMoa1215134
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676. https://doi.org/10.1016/j.cell.2006.07.024
Hanna JH, Saha K, Jaenisch R (2010) Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 143(4):508–525. https://doi.org/10.1016/j.cell.2010.10.008
Kanherkar RR, Bhatia-Dey N, Makarev E, Csoka AB (2014) Cellular reprogramming for understanding and treating human disease. Front Cell Dev Biol 2:67. https://doi.org/10.3389/fcell.2014.00067
Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS, Ko S, Yang E, Cha KY, Lanza R, Kim KS (2009) Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4(6):472–476. https://doi.org/10.1016/j.stem.2009.05.005
Zhang Y, Huang XR, Wei LH, Chung ACK, Yu CM, Lan HY (2014) miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-beta/Smad3 signaling. Mol Ther 22(5):974–985
van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. P Natl Acad Sci USA 105(35):13027–13032. https://doi.org/10.1073/pnas.0805038105
Chang L, Bertani P, Gallego-Perez D, Yang Z, Chen F, Chiang C, Malkoc V, Kuang T, Gao K, Lee LJ, Lu W (2016) 3D nanochannel electroporation for high-throughput cell transfection with high uniformity and dosage control. Nanoscale 8(1):243–252. https://doi.org/10.1039/c5nr03187g
Chang L, Gallego-Perez D, Zhao X, Bertani P, Yang Z, Chiang CL, Malkoc V, Shi J, Sen CK, Odonnell L, Yu J, Lu W, Lee LJ (2015) Dielectrophoresis-assisted 3D nanoelectroporation for non-viral cell transfection in adoptive immunotherapy. Lab Chip 15(15):3147–3153. https://doi.org/10.1039/c5lc00553a
Chang L, Gallego-Perez D, Chiang CL, Bertani P, Kuang T, Sheng Y, Chen F, Chen Z, Shi J, Yang H, Huang X, Malkoc V, Lu W, Lee LJ (2016) Controllable large-scale transfection of primary mammalian cardiomyocytes on a nanochannel array platform. Small 12(43):5971–5980. https://doi.org/10.1002/smll.201601465
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Chang, L., Chitrakar, C., Nouri, M. (2020). 3D Nanochannel Electroporation for Macromolecular Nucleotide Delivery. In: Li, S., Chang, L., Teissie, J. (eds) Electroporation Protocols. Methods in Molecular Biology, vol 2050. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9740-4_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9740-4_7
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9739-8
Online ISBN: 978-1-4939-9740-4
eBook Packages: Springer Protocols